SHANGHAI, June 15 -- Chinese and American scientists have jointly developed a new antibody targeting the Middle East Respiratory Syndrome (MERS) virus, which has killed 16 people and landed 150 others in hospital.
Fudan University, which worked with U.S. National Institutes of Health to develop the antibody, said on Monday that tests on animals had seen "very effective" results.
Jiang Shibo, who led the research team at Fudan, said the m336 antibody could neutralize MERS virus more effectively than other antibodies.
Zhong Nanshan, a renowned respiratory expert, called for an immediate clinical trial.
The m336 antibody treatment has proved more effective when coupled with a specific type of polypeptide, according to Jiang.
Abandoned village swallowed by nature
Graduation: the time to show beauty in strength
School life of students in a military college
Top 16 Chinese cities with the best air quality in 2014
Mysterious “sky road” in Mount Dawagengzha
Students with Weifang Medical University take graduation photos
PLA soldiers conduct 10-kilometer long range raid
Stars who aced national exams
PLA helicopters travel 2,000 kilometers in maneuver drill
Hillary’s speech offers clue to Sino-US ties
'Smile diary' helps mother cope with son's leukemia 
Make me a genius
Weak yen weighing on China’s exportsDay|Week
